Feasibility of a clinical trial of vision therapy for treatment of amblyopia

  • Don W. Lyon
  • , Kristine Hopkins
  • , Raymond H. Chu
  • , Susanna M. Tamkins
  • , Susan A. Cotter
  • , B. Michele Melia
  • , Jonathan M. Holmes
  • , Michael X. Repka
  • , David T. Wheeler
  • , Nicholas A. Sala
  • , Janette Dumas
  • , David I. Silbert

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Purpose: We conducted a pilot randomized clinical trial of office-based active vision therapy for the treatment of childhood amblyopia to determine the feasibility of conducting a full-scale randomized clinical trial. Methods: A training and certification program and manual of procedures were developed to certify therapists to administer a standardized vision therapy program in ophthalmology and optometry offices consisting of weekly visits for 16 weeks. Nineteen children, aged 7 to less than 13 years, with amblyopia (20/40-20/100) were randomly assigned to receive either 2 hours of daily patching with active vision therapy or 2 hours of daily patching with placebo vision therapy. Results: Therapists in diverse practice settings were successfully trained and certified to perform standardized vision therapy in strict adherence with protocol. Subjects completed 85% of required weekly in-office vision therapy visits. Eligibility criteria based on age, visual acuity, and stereoacuity, designed to identify children able to complete a standardized vision therapy program and judged likely to benefit from this treatment, led to a high proportion of screened subjects being judged ineligible, resulting in insufficient recruitment. There were difficulties in retrieving adherence data for the computerized home therapy procedures. Conclusions: This study demonstrated that a 16-week treatment trial of vision therapy was feasible with respect to maintaining protocol adherence; however, recruitment under the proposed eligibility criteria, necessitated by the standardized approach to vision therapy, was not successful. A randomized clinical trial of in-office vision therapy for the treatment of amblyopia would require broadening of the eligibility criteria and improved methods to gather objective data regarding the home therapy. A more flexible approach that customizes vision therapy based on subject age, visual acuity, and stereopsis might be required to allow enrollment of a broader group of subjects.

Original languageEnglish (US)
Pages (from-to)475-481
Number of pages7
JournalOptometry and Vision Science
Volume90
Issue number5
DOIs
StatePublished - May 2013
Externally publishedYes

Keywords

  • amblyopia
  • masking
  • patching
  • placebo vision therapy
  • vision therapy

ASJC Scopus subject areas

  • Ophthalmology
  • Optometry

Fingerprint

Dive into the research topics of 'Feasibility of a clinical trial of vision therapy for treatment of amblyopia'. Together they form a unique fingerprint.

Cite this